More on GRAL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (5.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GRAIL, Inc. (NQ:GRAL)
Delayed: 77.48 -1.62 (2.05%)
Prev. Close $79.10  
Open$78.96 
52 Wk High$ 
52 Wk Low$ 
Day High$81.18 
Day Low$76.99 
P/E N/A  
EPS$ 
Volume591,077 

Friends, Peers and Foes (?): GRAL.V, WGS, BMI, VRRM, PACB (more...)

Sep 9, 2026 06:08 AM UBS Assumes GRAIL, Inc. (GRAL) at Buy
Sep 3, 2026 07:06 AM GRAIL, Inc. (GRAL) PT Raised to $86 at Baird
Aug 27, 2026 04:26 PM Form 144 GRAIL, Inc. Filed by: Ofman Joshua J.
Aug 27, 2026 04:19 PM Form 144 GRAIL, Inc. Filed by: Freidin Aaron
Aug 13, 2026 05:15 PM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 7, 2026 11:05 AM FDA panel set to review GRAIL's multi-cancer blood test application
Aug 7, 2026 11:05 AM GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
Aug 7, 2026 09:44 AM Form SCHEDULE 13G GRAIL, Inc. Filed by: STATE STREET CORP
Aug 6, 2026 05:02 PM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: PRIMECAP MANAGEMENT CO/CA/
Aug 6, 2026 04:17 PM Form 10-Q GRAIL, Inc. For: Jun 30
View All Articles

Entities mentioned with GRAL

View All Entities